Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering

被引:403
作者
Habraken, W. J. E. M. [1 ]
Wolke, J. G. C. [1 ]
Jansen, J. A. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Coll Dent Sci, Dept Periodont & Biomat, NL-6500 HB Nijmegen, Netherlands
关键词
ceramics; cements; bioactive glass; ceramic/polymer composites; drug release; growth factors; CALCIUM-PHOSPHATE CEMENT; BONE INDUCTIVE PROPERTIES; GROWTH-FACTOR BETA-1; COLLAGEN TYPE-I; CONTROLLED-RELEASE; BIOACTIVE GLASS; MECHANICAL-PROPERTIES; HYDROXYAPATITE SCAFFOLDS; TRICALCIUM PHOSPHATE; PHYSICAL-PROPERTIES;
D O I
10.1016/j.addr.2007.03.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Ceramic composites and scaffolds are popular implant materials in the field of dentistry, orthopedics and plastic surgery. For bone tissue engineering especially CaP-ceramics or cements and bioactive glass are suitable implant materials due to their osteoconductive properties. In this review the applicability of these ceramics but also of ceramic/polymer composites for bone tissue engineering is discussed, and in particular their use as drug delivery systems. Overall, the high density and slow biodegradability of ceramics is not beneficial for tissue engineering purposes. To address these issues, macroporosity can be introduced often in combination with osteoinductive growth factors and cells. Ceramics are good carriers for drugs, in which release patterns are strongly dependent on the chemical consistancy of the ceramic, type of drug and drug loading. Biodegradable polymers like polylactic acid, gelatin or chitosan are used as matrices for ceramic particles or as adjuvant to calcium phosphate cements. The use of these polymers can introduce a tailored biodegradation/drug release to the ceramic material. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:234 / 248
页数:15
相关论文
共 133 条
[1]   Fabrication of low temperature macroporous hydroxyapatite scaffolds by foaming and hydrolysis of an α-TCP paste [J].
Almirall, A ;
Larrecq, G ;
Delgado, JA ;
Martínez, S ;
Planell, JA ;
Ginebra, MP .
BIOMATERIALS, 2004, 25 (17) :3671-3680
[2]  
Ambrosio AMA, 2001, J BIOMED MATER RES, V58, P295, DOI 10.1002/1097-4636(2001)58:3<295::AID-JBM1020>3.0.CO
[3]  
2-8
[4]   Alginate hydrogels as biomaterials [J].
Augst, Alexander D. ;
Kong, Hyun Joon ;
Mooney, David J. .
MACROMOLECULAR BIOSCIENCE, 2006, 6 (08) :623-633
[5]  
BARSOUM MW, 1997, MCGRAW HILL SERIES M, P2
[6]   Normal and osteopenic bone-derived osteoblast response to a biomimetic gelatin-calcium phosphate bone cement [J].
Bigi, A. ;
Panzavolta, S. ;
Sturba, L. ;
Torricelli, P. ;
Fini, M. ;
Giardino, R. .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2006, 78A (04) :739-745
[7]   A biomimetic gelatin-calcium phosphate bone cement [J].
Bigi, A ;
Torricelli, P ;
Fini, M ;
Bracci, B ;
Panzavolta, S ;
Sturba, L ;
Giardino, R .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2004, 27 (08) :664-673
[8]   Effect of added gelatin on the properties of calcium phosphate cement [J].
Bigi, A ;
Bracci, B ;
Panzavolta, S .
BIOMATERIALS, 2004, 25 (14) :2893-2899
[9]   Biomimetic growth of hydroxyapatite on gelatin films doped with sodium polyacrylate [J].
Bigi, A ;
Boanini, E ;
Panzavolta, S ;
Roveri, N .
BIOMACROMOLECULES, 2000, 1 (04) :752-756
[10]   Clinical indications of calcium-phosphate biomaterials and related composites for orthopedic procedures [J].
Block, JE ;
Thorn, MR .
CALCIFIED TISSUE INTERNATIONAL, 2000, 66 (03) :234-238